WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics ®, a clinical-stage biopharmaceutical company, today announced positive data from the STARLYNG-1 (LYN-005-C-301) study, comparing the ...
Add Yahoo as a preferred source to see more of our stories on Google. Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials ...
In the phase 3 study, QWINT-1, efsitora was administered via four fixed doses once weekly in a single-use autoinjector in people with type 2 diabetes using basal insulin for the first time In a second ...
LYN-005 is an investigational long-acting oral capsule formulation of the atypical antipsychotic risperidone. Positive data were announced from a phase 3 study comparing the pharmacokinetic (PK) ...
Research on the influence of cannabis use on cardiovascular functions, pulmonary functions, and other indicators is still growing, but one new study has shed new light on the topic. “The effects of ...
Engaging in 150 minutes of consistent aerobic weekly exercise may help keep your brain younger, according to recent findings from a study published in the current issue of the Journal of Sport and ...
NUS study: Brief weekly magnetic muscle therapy improves mobility and lean body mass in older adults
A decline in functional mobility, loss of muscle strength and an increase in body fats are often associated with ageing. This trend could potentially be reversed by way of an innovative magnetic ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics, a clinical-stage biopharmaceutical company working to make daily pills a thing of the past, today announced it has dosed the first participant ...
Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called efsitora alfa has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results